VinFuture and the European Molecular Biology Organization (EMBO) co-organized a webinar on regenerative medicine
The inaugural 2025 InnovaTalk webinar, convened on March 27th, achieved a substantial global impact, attracting over 130 leading experts in regenerative medicine. Participants representing 24 countries across five continents engaged in a dynamic discussion on this critical biomedical frontier. The webinar, chaired by Professor Fiona Watt, Member of the VinFuture Prize Pre-Screening Committee and Director of EMBO (Germany), alongside esteemed scientists Professor James Bainbridge and Dr. Linh Nguyen (University College London, UK), and Dr. Cristiana Pires (Asgard Therapeutics, Sweden), delivered comprehensive and insightful presentations, providing a valuable global perspective on this promising field.
In this InnovaTalk webinar, the expert panel highlighted recent advancements in the field of regenerative medicines, as well as assessed the current challenges hindering the widespread clinical application of these therapies. They emphasized a shared dedication to accelerating practical application through strategic global collaborations, aimed at expanding both research and therapeutic implementation.
The inaugural 2025 InnovaTalk webinar, convened on March 27th, achieved a substantial global impact, attracting over 130 leading experts in regenerative medicine. Participants representing 24 countries across five continents engaged in a dynamic discussion on this critical biomedical frontier. The webinar, chaired by Professor Fiona Watt, Member of the VinFuture Prize Pre-Screening Committee and Director of EMBO (Germany), alongside esteemed scientists Professor James Bainbridge and Dr. Linh Nguyen (University College London, UK), and Dr. Cristiana Pires (Asgard Therapeutics, Sweden), delivered comprehensive and insightful presentations, providing a valuable global perspective on this promising field.
In this InnovaTalk webinar, the expert panel highlighted recent advancements in the field of regenerative medicines, as well as assessed the current challenges hindering the widespread clinical application of these therapies. They emphasized a shared dedication to accelerating practical application through strategic global collaborations, aimed at expanding both research and therapeutic implementation.
- Catégories
- Webinar
Commentaires